Glipizide Tablet, Extended Release
Product Images NDC 70518-3898

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 70518-3898). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Glipizide 5 mg extended-release oral tablets label showing a quantity of 90 tablets. The label includes the NDC number 70518-3898-00 and states it is for prescription use only. The manufacturer is Aurobindo Pharma, Hyderabad, India, with repackaging by RemedyRepack Inc., Indiana. Storage instructions and a QR code are also visible.*

FDA Label Image

Mm2 (Glipizide 5mg 70518 3898 01)

Label for Glipizide 5 mg extended release oral tablets. The package contains 30 tablets and advises protection from moisture and humidity. The label includes the NDC 70518-3898-01, manufacturer information for Aurobindo Pharma in Hyderabad, India, and repackager RemedyRepack Inc., Indiana, PA. Storage instructions and directions to see the package insert are noted.*

FDA Label Image

Chemical Structure (Glipizide Str)

Chemical structure of glipizide showing its molecular arrangement with pyridine, sulfonyl, amide, and cyclohexyl groups as part of its extended release oral tablet formulation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.